Brief: Immunovia Q3 Revenue SEK 235 Thousand
27/11/2024 07:30
Nov 27 (Reuters) - Immunovia Q3 net income SEK -51.1 million. * Q3 adjusted EPS SEK -0.73 * Q3 adjusted free cash flow SEK -21.2 million
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study